-
公开(公告)号:US20050192306A1
公开(公告)日:2005-09-01
申请号:US11119653
申请日:2005-05-02
申请人: Jennifer Doughty , Richard Green , Charles Hartley , Alan Naylor , Jeremy Payne , Neil Pegg
发明人: Jennifer Doughty , Richard Green , Charles Hartley , Alan Naylor , Jeremy Payne , Neil Pegg
IPC分类号: A61K31/505 , A61P1/00 , A61P1/04 , A61P1/16 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/02 , A61P19/06 , A61P21/00 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P29/00 , A61P31/12 , A61P31/16 , A61P35/00 , A61P43/00 , C07D239/42
CPC分类号: C07D239/42
摘要: Methods of treating a subject suffering from a condition which is mediated by COX-2.
摘要翻译: 治疗患有COX-2介导的病症的受试者的方法。
-
公开(公告)号:US20060240048A1
公开(公告)日:2006-10-26
申请号:US10528613
申请日:2003-09-25
申请人: Andrew Eatherton , Gerard Martin Giblin , Richard Green , Jennifer Doughty , Karamjit Jandu , William Mitchell , Alan Naylor , Giovanni Palombi , Derek Rawlings , Brian Slingsby , Andrew Whittington
发明人: Andrew Eatherton , Gerard Martin Giblin , Richard Green , Jennifer Doughty , Karamjit Jandu , William Mitchell , Alan Naylor , Giovanni Palombi , Derek Rawlings , Brian Slingsby , Andrew Whittington
IPC分类号: A61K47/00
CPC分类号: C07D213/82 , C07D401/06 , C07D403/06 , C07D405/12 , C07D409/12
摘要: The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
摘要翻译: 本发明涉及新颖的吡啶衍生物,含有这些化合物的药物组合物及其在治疗疾病尤其是疼痛中的用途,所述疾病通过大麻素受体的活性的增加或减少而直接或间接引起。
-
公开(公告)号:US07074802B2
公开(公告)日:2006-07-11
申请号:US10477819
申请日:2002-05-23
申请人: Jennifer Doughty, legal representative , Charles David Hartley , Alan Naylor , Jeremy John Payne , Neil Anthony Pegg
IPC分类号: C07D239/42 , A61K31/505
CPC分类号: C07D239/42
摘要: The invention thus provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl and C4-12bridged cycloalkyl; R3 is selected from the group consisting of C1-6alkyl, NH2 and R5CONH; R4 is selected from the group consisting of CH2F, CHF2, CF3CH2, CF3CHF and CF3CF2; and R5 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.
摘要翻译: 因此,本发明提供式(I)化合物及其药学上可接受的盐,其中:R 1和R 2独立地选自H,C C 1-6烷基,C 2-6链烯基,C 3-6亚炔基,C 3-10环烷基C 0-6个烷基和C 4-12-12桥连环烷基; R 3选自C 1-6烷基,NH 2和R 5 CONH; R 4选自CH 2,CH 2,CH 3,CH 3,CH 3,CH 3, 2,CF 3 CHF和CF 3 3 CF 2; 和R 5选自H,C 1-6烷基,C 1-6烷氧基,C 1 C 1-6烷基,C 1-6烷基,苯基,HO 2 C 1-6烷基,C 1-6 C 1-6烷基,C 1-6烷基,C 1 -C 6烷基,C 1 -C 6烷基,C 1 -C 6烷基, 烷基,C 1-6烷基,C 1-6烷基和C 1-6烷基CONHC 1-6烷基。 式(I)化合物是COX-2的有效和选择性抑制剂,可用于治疗疼痛,发热,各种病症和疾病的炎症。
-
公开(公告)号:US20070129367A1
公开(公告)日:2007-06-07
申请号:US10528592
申请日:2003-09-25
申请人: Andrew Eatherton , Gerard Giblin , Richard Green , Jennifer Doughty , Karamjit Jandu , William Mitchell , Alan Naylor , Giovanni Palombi , Derek Rawlings , Brian Slingsby , Andrew Whittington
发明人: Andrew Eatherton , Gerard Giblin , Richard Green , Jennifer Doughty , Karamjit Jandu , William Mitchell , Alan Naylor , Giovanni Palombi , Derek Rawlings , Brian Slingsby , Andrew Whittington
IPC分类号: A61K31/53 , A61K31/501 , A61K31/506 , A61K31/497 , A61K31/4439 , C07D417/02 , C07D413/02 , C07D403/02 , C07D401/02
CPC分类号: C07D213/82 , C07D401/12 , C07D413/12
摘要: The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
摘要翻译: 本发明涉及新颖的吡啶衍生物,含有这些化合物的药物组合物及其在治疗疾病尤其是疼痛中的用途,该疾病通过大麻素受体的活性的增加或减少直接或间接引起。
-
公开(公告)号:US20060247261A1
公开(公告)日:2006-11-02
申请号:US10524469
申请日:2003-08-19
申请人: Andrew Eatherton , Gerard Giblin , Richard Green , Jennifer Doughty , William Mitchell , Alan Naylor , Derek Rawlings , Brian Slingsby , Andrew Whittington
发明人: Andrew Eatherton , Gerard Giblin , Richard Green , Jennifer Doughty , William Mitchell , Alan Naylor , Derek Rawlings , Brian Slingsby , Andrew Whittington
IPC分类号: A61K31/506 , A61K31/505 , C07D403/02
CPC分类号: C07D239/42 , C07D401/12
摘要: The present invention relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
摘要翻译: 本发明涉及新颖的嘧啶衍生物,含有这些化合物的药物组合物及其在治疗疾病尤其是疼痛中的用途,该疾病是由大麻素受体的活性的增加或减少直接或间接引起的。
-
公开(公告)号:US20050032823A1
公开(公告)日:2005-02-10
申请号:US10477819
申请日:2002-05-23
申请人: Richard Doughty , Jennifer Doughty Green , Charles Hartley , Alan Naylor , Jeremy Payne , Neil Pegg
发明人: Richard Doughty , Jennifer Doughty Green , Charles Hartley , Alan Naylor , Jeremy Payne , Neil Pegg
IPC分类号: A61K31/505 , A61P1/00 , A61P1/04 , A61P1/16 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/02 , A61P19/06 , A61P21/00 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P29/00 , A61P31/12 , A61P31/16 , A61P35/00 , A61P43/00 , C07D239/42 , C07D239/02
CPC分类号: C07D239/42
摘要: The invention thus provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C2-6alkenyl, C3-4alkynyl, C3-10cycloalkylC0-6alkyl and C4-12bridged cycloalkyl; R3 is selected from the group consisting of C1-6alkyl, NH2 and R5CONH; R4 is selected from the group consisting of CH2F, CHF2, CF3CH2, CF3CHF and CF3CF2; and R5 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO 2cc1-6?alkyl, C1-6alkylOCOC1-6alkyl, C1-4alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.
摘要翻译: 因此,本发明提供式(I)化合物及其药学上可接受的盐,其中:R 1和R 2独立地选自H,C 1-6烷基,C 2-6烯基,C 3-4炔基 ,C 3-10环烷基C 1-6烷基和C 4-12桥环烷基; R 3选自C 1-6烷基,NH 2和R 5 CONH; R 4选自CH 2 F,CHF 2,CF 3 CH 2,CF 3 CHF和CF 3 CF 2; 并且R 5选自H,C 1-6烷基,C 1-6烷氧基,C 1-6烷基C 1-6烷基,苯基,HO
2 C 1-6烷基,C 1-6烷基COC 1-6烷基,C 1-4烷基COO,H 2 NC 1-6烷基,C 1-6烷基OCONHC 1-6烷基和C 1-6烷基CONHC -6-烷基。 式(I)化合物是COX-2的有效和选择性抑制剂,可用于治疗疼痛,发热,各种病症和疾病的炎症。
-
-
-
-
-